Search
forResearch 10 of 1000+
- Immune therapies for alopecia areata: evidence and new perspectives
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dendritic cell subsets in alopecia areata: focus on plasmacytoid dendritic cells and Langerhans cells in immune imbalance and therapeutic implications
- 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
- Immunotherapies
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- Topical immunotherapies
- Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies